The Legal 500

Work Department

Corporate practice group.

Position

Tim Corbett is a partner in the corporate practice group and a member of the firm’s international transactions group. Joined the firm in 1997 and has been resident in the London office since 1999. His practice focuses on cross-border corporate transactions, including mergers and acquisitions, public and private securities offerings, and venture capital financings. He also advises US and European clients on general corporate governance, securities law compliance and disclosure requirements and practices. He has extensive experience with transactions in Russia, Germany, Switzerland, France, Spain and the Netherlands, in addition to the US and the UK. His clients include a wide range of companies in the life sciences, technology and media sectors, including biotechnology; internet, e-commerce and digital media; television broadcasting; and semiconductor design and manufacture. Highlights include: represented BioVex Group, Inc., a biotechnology company, in its sale to Amgen Inc for up to $1bn cash; represented 7digital, a digital media company, in its joint venture with HMV Group; represented Zipcar, the car sharing company, in its acquisition of Streetcar Limited; represented Figleaves.com, an online retailer, in the sale of its business to JD Williams; represented Glasses Direct, an online eyewear retailer, in its acquisition of Sunglasses Shop; represented CTC Media, a Russia television broadcaster, in its initial public offering on Nasdaq; represented CTC Media in its acquisitions of the DTV television network in Russia and Channel 31 Group in Kazakhstan; represented the government of Greece in the privatisation of Olympic Airlines; represented the underwriters in the €6bn initial public offering of Infineon Technologies, the former semiconductor business of Siemens AG, on the New York Stock Exchange and Frankfurt Stock Exchange; represented TEMENOS Group, a Swiss banking software company, and Speedel Holdings, a Swiss biopharmaceutical company, in their initial public offerings on the SWX Swiss Stock Exchange; represented Azea Networks, a submarine network technology company, in its merger with Xtera Communications; represented Oxxon Therapeutics, a biotech company, in its sale to Oxford BioMedica plc; represented Parthus Technologies, a semiconductor design company, in its initial public offering on Nasdaq and the London Stock Exchange and its merger with CEVA, Inc.; represented numerous venture-backed companies in cross-border venture equity and debt financings.

Career

Qualified 1997. Policy analyst, US department of health and human services, 1990-94. WilmerHale, Boston 1997-1999, London 1999-to date; partner 2009.

Languages

German

Education

Boston College High School; Harvard College (1989 BA); New York University School of Law (1997 JD).

Leisure

Harvard Club of the United Kingdom.

Practice Areas

Corporate and commercial; M&A; Private equity